Non-Surgical Rhinoplasty Explained

Two (2.8%) patients required a touchup after 15 days, both of them desiring further dorsal correction. A statistically significant improvement was found in all domains of the rhinoplasty module of the FACE-Q and in the overall scores. Supratip break, lobule elongation, and lobulocolumellar angle are addressed with a “retraction–pinching” maneuver.
Silicone, primarily silicon dioxide-based, is a chemically inert material historically used for soft tissue augmentation since the 1950s due to its low cost, stability, and theoretical biocompatibility. However, the absence of standardized formulations, injection protocols, and long-term safety data has relegated it to a non-standard, high-risk 超声刀 英文 option in modern aesthetic practice. Silicone can cause irreversible adverse effects, including skin swelling, scarring, and facial deformities [86,87]. Injectable liquid silicone has been widely used for soft tissue augmentation owing to its ease of administration. Case reports have documented nasal contracture following silicone implant rhinoplasty, in which severe contracture can affect all layers of the nose, resulting in significant scarring and disfigurement [89,90].

The aim of this study is to describe the author’s experience with nonsurgical nasal reshaping, focusing on the indications and maneuvers to safely achieve, by mean of HA, the grafts previously described for surgical rhinoplasty. Scrolling through Instagram Stories the other night, however, a certain post about this procedure gave me pause. When I tuned in, she was talking filler complications, and addressing the nonsurgical nose job, specifically, sharing that she refuses to offer it, because the risks can be catastrophic. The volume of the product at each episode was low (mean volume used 0.23 mL) and the number of areas injected at each episode was multiple (mean number of injection points 1.94). If a cannula had been used then the number of injection points would have been impossible to count, as a cannula can cover a wide area of treatment through a single injection point. Using our technique of bolus injections with a needle, with the filler placed deep around the skeletal framework of the nose allows for targeted small-volume product placement.
Table 3 indicates an overall postoperative complication rate of 14.5%. Most of these resolved rapidly based on a “wait and see” approach within about 2 days. Specific treatments include icing for bruising [49], massage for asymmetry [22], hot moist compresses for hematomas [22], and oral corticosteroids [24] (e.g., triamcinolone acetonide [26]) for advanced edema. In case of serious complications such as infection or skin necrosis, administer antibiotics, and steroid (e.g., dexamethasone) [13] in the first instance and consider dissolving the filler with hyaluronidase [26]. Severe asymmetries are also treated with hyaluronidase applied according to the patient's needs [49].

Liquid nose job offers a safe, non-surgical way to refine nasal contours with dermal fillers. Different injection protocols are differentiated by the patient's condition, in addition to complications, satisfaction, ethnicity, and clinician's preferences, all of which influence the choice of protocol. Exactly, bottom-up injections minimize the amount of fill in this area. Erythema, bruising, and swelling are commonly reported complications in the bottom-up and top-to-bottom approaches. The literature included in this paper consists mainly of Retrospective literature, Case reports, Randomized Controlled Trials, and Non-Randomized Trials. Narrative Reviews, Systematic Reviews, Technical Reports, Expert Opinions, Descriptive studies, etc., were excluded from the section on data collation regarding complication rates.
Identified literature was systematically analyzed to synthesize evidence on filler mechanisms, clinical applications, and safety management strategies. In recent years, an aging population, heightened awareness of aesthetic appearance, and advances in medical aesthetic technology have fueled a boom in the global medical aesthetic surgery industry [1]. The global medical aesthetics market is projected to approach $125  billion by 2028, underscoring the widespread and increasing use of aesthetic procedures and the accompanying need for stricter safety protocols and clinical guidelines. A survey by the American Society for Dermatologic Surgery indicates that approximately 70% of consumers consider cosmetic surgery to enhance self-confidence and to appear younger and more attractive. Worldwide, minimally invasive and facial injectable filler procedures are gaining popularity [2]. Aesthetic medicine, a medical specialty focused on enhancing physical appearance through minimally invasive or nonsurgical methods, is all about symmetry, proportion, and patient satisfaction [4].
For large humps, surgical rhinoplasty is the appropriate intervention. In clinical practice, nose filler results typically persist for 12–18 months. The nasal region is a relatively low-movement area compared to lips or forehead, which contributes to longevity at the longer end of this range for many patients. Nose filler works through the strategic addition of volume, it does not remove tissue or physically restructure bone or cartilage. This is the most important distinction between nose filler and surgical rhinoplasty. If you're considering undergoing treatment via a non-surgical nose job, make an appointment with a board-certified dermatologist and/or cosmetic surgeon beforehand to figure out your options.

Prices for the procedure depend on the provider, but the average cost of a non-surgical nose job is typically around $1,000. When performing the procedure, all structures of the nose—including the thicknesses and properties of the skin and soft tissue and the size, shape, and strength of the cartilage and bone—should be taken into account in order to avoid complications. We analyzed the clinical data of 44 patients who underwent nasal filling with hyaluronic acid between December 2016 and July 2017. All patients signed a consent form and were informed about the  procedure.
Photoconsent was provided by individuals whose photos appear in this article. Besides treating patients, Alisha is also a researcher and educator at Dr Tim Ltd, a renowned aesthetics training company. She develops courses that trains thousands of medical practitioners each year on the latest techniques and safety practices. Non-surgical rhinoplasty primarily addresses cosmetic concerns by enhancing shape and symmetry. It cannot resolve underlying functional problems like breathing difficulties caused by structural issues in the nose. When considering a liquid nose job, it’s important to select a reputable clinic that adheres to strict hygiene practices.
Siperstein et al.7 discusses the application of a 27-gauge cannula in aesthetic medicine, highlighting its benefits and challenges in their article. The author emphasizes that the use of a 27-gauge cannula can enhance patient safety by reducing the risk of vascular complications and bruising during injectable procedures. He outlines the advantages of this gauge size, including improved precision and reduced discomfort for patients. However, Siperstein also addresses potential drawbacks, such as the need for greater skill and technique when using a cannula compared to traditional needles. The article advocates for proper training and understanding of anatomical considerations to maximize the efficacy and safety of cannula use in aesthetic practices (Level IV).

Practitioners should be well-trained in both methods to tailor their approach to individual patient needs and specific anatomical considerations. In translating the above evidence into practice, we recommend a region-tailored approach that balances vascular risk, plane selection, and the need for precision. In the forehead/temple (supraorbital/supratrochlear territory), a cannula in deep, gliding planes with micro-aliquots is preferred; ultrasound is advisable near sentinel vessels. For the periorbital/tear trough, favor a 25–27 G cannula in a pre-periosteal or deep sub-orbicularis plane, avoiding boluses and confirming placement with ultrasound when available.
Additionally, the authors noted that patients experienced less discomfort and faster recovery times with cannula use. While efficacy in terms of aesthetic outcomes was comparable between the two methods, the findings strongly support the argument that cannulas may be the safer option, particularly in sensitive areas where vascular structures are prevalent. The authors conclude that the choice of injection method should consider both safety and patient comfort, advocating for the use of cannulas in appropriate clinical scenarios (Level Ia). There is no doubt, though, that vascular anatomy is altered following surgery. The nose has arterial supply through both internal and external carotid systems through  vessels such as the dorsal nasal artery, the supratrochlear artery, lateral nasal artery, the angular artery, the anterior ethmoidal artery, and so on.

Thread lifting has become an increasingly popular aesthetic procedure due to its effective lifting capabilities and reduced downtime compared to traditional surgical methods. Nonsurgical cosmetic interventions are highly sought after, as many patients have demanding schedules and prefer treatments that yield quick results with minimal complications and social downtime. The long‐term efficacy assessment showed a decrease in nose FACE‐Q score in the Filler + BTX group to 22.9 ± 3.0 one‐year posttreatment. Similarly, the Threads + BTX group showed a decrease to 25.1 ± 2.9 at 1 year.
A summary of the characteristics of all articles included is provided in Table 5. The true incidence of adverse events is likely underestimated due to several biases inherent to the filler literature. First, selective non-publication and preferential reporting of favorable outcomes skew the evidence base toward success, while complications—especially severe but rare events—are less likely to be submitted or accepted. Second, most complication data rely on passive or voluntary reporting, with additional medicolegal disincentives that suppress disclosure.